相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Application of Molecular Modeling to Development of New Factor Xa Inhibitors
Vladimir B. Sulimov et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
Charles Frost et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Application of the Docking Program SOL for CSAR Benchmark
Alexey V. Sulimov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
Bengt I. Eriksson et al.
CLINICAL PHARMACOKINETICS (2009)
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery
B. I. Eriksson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Design, synthesis and melatoninergic activity of new unsubstituted and β,β′-difunctionalised 2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-alkanamides
Andrew Tsotinis et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2007)
Oral, direct Factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases
Alexander G. G. Turpie
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The discovery of the factor Xa inhibitor otamixaban: From lead identification to clinical development
Kevin R. Guertin et al.
CURRENT MEDICINAL CHEMISTRY (2007)
New anticoagulants: Anti IIa vs anti Xa - Is one better?
KA Bauer
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Analyses of activity for factor Xa inhibitors based on Monte Carlo simulations
D Ostrovsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor:: Potential therapeutic applications for epilepsy and obesity
M Isaac et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
分享论文
